Don’t be afraid of the FDA
July 6, 2021 9:00 am Comments Off on Don’t be afraid of the FDAhttps://hvivo.com/wp-content/uploads/2021/07/FDA_SvdS.pdf
Author Archives for Neil Kerly
Rolling Reviews – a useful tool to speed up the regulatory review process
April 23, 2021 9:17 am Comments Off on Rolling Reviews – a useful tool to speed up the regulatory review processhttps://hvivo.com/wp-content/uploads/2021/04/Speder-Bruno-Rolling-Reviews-Feature-May-2021.pdf
Temporal relationships of cytokines, chemokines and cellular biomarkers during Human Rhinovirus (HRV) infection in asthmatics
September 30, 2019 5:39 pm Comments Off on Temporal relationships of cytokines, chemokines and cellular biomarkers during Human Rhinovirus (HRV) infection in asthmaticshttps://hvivo.com/wp-content/uploads/2019/09/ERS-presentation-template-Madrid-2019-FINAL-30.09.19.pdf
A Key Endpoint in Viral Challenge Models of Asthma Exacerbations
September 27, 2019 4:48 pm Comments Off on A Key Endpoint in Viral Challenge Models of Asthma Exacerbationshttps://hvivo.com/wp-content/uploads/2019/09/ERS-2019-Ghebre-et-al-25.09.19-FINAL.pdf
hVIVO to present at upcoming 2019 European Respiratory Society (ERS) International Congress in Madrid, Spain
September 26, 2019 3:24 pm Comments Off on hVIVO to present at upcoming 2019 European Respiratory Society (ERS) International Congress in Madrid, SpainPre-existing NP specific T-cell response correlates with reduction of symptoms in a human influenza challenge model
September 25, 2019 11:58 am Comments Off on Pre-existing NP specific T-cell response correlates with reduction of symptoms in a human influenza challenge modelhttps://hvivo.com/wp-content/uploads/2019/10/190831-OptionsX-Pre-existing-NP-T-cell-response-in-HCS-vf.pdf
THE HUMAN VIRAL CHALLENGE MODEL WITH A/PERTH/16/2009 H3N2A SYSTEMATIC ANALYSIS FROM FIVE CLINICAL STUDIES
September 23, 2019 12:05 pm Comments Off on THE HUMAN VIRAL CHALLENGE MODEL WITH A/PERTH/16/2009 H3N2A SYSTEMATIC ANALYSIS FROM FIVE CLINICAL STUDIEShttps://hvivo.com/wp-content/uploads/2019/10/hVIVO_ISIRV-Options-2019_Meta-analysis-H3N2-Perth.pdf
Join us! hVIVO presenting two posters and an oral presentation at the ISIRV Options X conference, Singapore, Asia, August 2019
July 25, 2019 11:39 am Comments Off on Join us! hVIVO presenting two posters and an oral presentation at the ISIRV Options X conference, Singapore, Asia, August 2019ISIRV Options X Conference, August 28 – September 01, 2019, SUNTEC Singapore, Asia hVIVO is pleased to announce that one... View Article
hVIVO is Gold Sponsor and presenter at World Vaccine Congress, Washington DC, USA April 2019
April 11, 2019 11:27 am Comments Off on hVIVO is Gold Sponsor and presenter at World Vaccine Congress, Washington DC, USA April 2019WVC 2017, 14-17 April 2019, Renaissance Washington DC Downtown Hotel, Washington DC, USA hVIVO is proud to once again be... View Article
hVIVO and Imutex Limited to present at IVW 2019 conference, Edinburgh, Scotland, April
April 2, 2019 3:17 pm Comments Off on hVIVO and Imutex Limited to present at IVW 2019 conference, Edinburgh, Scotland, AprilInfluenza Vaccines For The World 2019, April 02 – 04, Edinburgh, Scotland. hVIVO and its joint venture, Imutex Limited, will... View Article